2013 BMT Tandem Meetings: Poster Session 2: Graft Processing

409

Retrospective Analysis of Intravenous DMSO Toxicity in Transplant Patients
Anupama Bekkem, M.D., VA Cinic; George Selby, M.D., The University of Oklahoma Health Sciences Center; Jennifer Holter Chakrabarty, M.D., University of Oklahoma -Peggy and Charles Stephenson Cancer Center

410

Enhanced Targeting B Cell Lymphoma/Leukemia (B-L/L) by Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer (NK) Cells Combined with a Histone Deacetylase Inhibitor, Romidepsin
Yay Chu, PhD, New York Medical College; Ashlin Yahr, New York Medical College; Lowrence Lo, New York Medical College; Janet Ayello, MS, MT(ASCP), New York Medical College; Jared Katz, New York Medical College; Mitchell S. Cairo, MD, New York Medical College

411

Comparison of GRAFT Content and Efficiency of T CELL Depletion in BONE Marrow and Peripheral Blood STEM CELLS Grafts After Manipulation by Three Negative or Positive CD34+ Selection Strategies
Nancy H Collins, PhD, Memorial Sloan-Kettering Cancer Center; David Kaminetzky, MD, New York University Medical Center; Guenther Koehne, MD, PhD, Memorial Sloan-Kettering Cancer Center; Molly Maloy, BA, Memorial Sloan-Kettering Cancer Center; Xiashe Chen, PhD, Memorial Sloan-Kettering Cancer Center; Katherine Smith, Memorial Sloan-Kettering Cancer Center; Sharon Bleau, BS, Memorial Sloan-Kettering Cancer Center; Jo-ann Tonon, BS, Memorial Sloan-Kettering Cancer Center; Richard Meagher, PhD, Memorial Sloan-Kettering Cancer Center; Esperanza Papadopoulos, MD, Memorial Sloan-Kettering Cancer Center; James Young, MD, FACP, Memorial Sloan-Kettering Cancer Center; Sergio A. Giralt, MD, Memorial Sloan-Kettering Cancer Center; Richard O'Reilly, MD, Memorial Sloan-Kettering Cancer Center; Ann A. Jakubowski, PhD MD, Memorial Sloan-Kettering Cancer Center

412

Comparison of GRAFT Content and Outcomes in BONE Marrow and PBPC Grafts After T CELL Depletion by Three Different Methods
Ann A. Jakubowski, PhD MD, Memorial Sloan-Kettering Cancer Center; Nancy H Collins, PhD, Memorial Sloan-Kettering Cancer Center

413

Cord Blood Storage for ≥ 5 Years Does Not Impact Engraftment
Simrit Parmar, MD, UT MD Anderson Cancer Center; Marcos de Lima, UT MD Anderson Cancer Center; Elizabeth J. Shpall, MD, UT MD Anderson Cancer Center; Gabriela Rondon, MD, The University of Texas MD Anderson Cancer Center

414

IL-15 Alone Supports in Vitro Generation of Polyclonal CTL From CD3/CD28 Co-Stimulated Expanded CB T Cells Against Leukemia Cells
Jeyaraj Antony, Ph.D, Children's Hospital of Pittsburgh of UPMC; Xiaohua Chen, Ph.D, Children's Hospital of Pittsburgh of UPMC; Paul Szabolcs, MD, University of Pittsburgh

415

Why Do Umbilical Cord Blood Units Fail to Qualify for Public Banking?
Jessica Wishnew, MD, Duke University Medical Center; Stephen Wease, MPH, EMMES Corporation; Jose Hernandez, MBA, Duke University; Kristin Page, MD, Duke University Medical Center; Joanne Kurtzberg, MD, Duke University Medical Center